![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 17, 8288-8292, Jun, 1987
MM Compton and JA Cidlowski
Glucocorticoids initiate a cytolytic process in lymphoid cells that is
characteristic of programmed cell death. In vivo treatment of
adrenalectomized rats with glucocorticoids results in the rapid degradation
of the thymocyte genome at internucleosomal sites. This DNA degradation
occurs prior to cell death, and considerable evidence indicates that this
nucleolytic event is central to the initiation of lymphocytolysis. To
further characterize this process, we have searched for the gene products
in thymocytes which may be responsible for steroid-induced DNA degradation.
Adrenalectomized rats were treated in vivo with dexamethasone or a vehicle
control; nuclear thymocyte proteins were extracted with 0.6 M NaCl and
analyzed for protein content or nuclease activity on sodium dodecyl
sulfatepolyacrylamide gels containing calf thymus DNA. Glucocorticoid
treatment resulted in the induction of two major protein families, a
30-32-kDa protein doublet and a series of 3-4 proteins of 12-19 kDa, both
of which express prominent DNase activity. Induction of the lower molecular
weight nucleases increased with time after steroid treatment and paralleled
the time course of glucocorticoid-mediated DNA degradation. Nuclease
induction was blocked by the glucocorticoid antagonist RU 486, indicating a
steroid receptor-mediated process. When nuclei from
glucocorticoid-resistant cells were incubated with nuclear extracts from
glucocorticoid-treated rats, the DNA was cleaved at internucleosomal sites,
whereas extracts from vehicle-treated animals were virtually inactive.
Based on these findings we propose that glucocorticoids, acting via a
receptor-mediated pathway, induce a nucleolytic "lysis gene" product(s)
responsible for lymphocytolysis.
Identification of a glucocorticoid-induced nuclease in thymocytes. A potential "lysis gene" product
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Pazirandeh, M. Jondal, and S. Okret Conditional Expression of a Glucocorticoid Receptor Transgene in Thymocytes Reveals a Role for Thymic-Derived Glucocorticoids in Thymopoiesis in Vivo Endocrinology, June 1, 2005; 146(6): 2501 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pazirandeh, M. Jondal, and S. Okret Glucocorticoids Delay Age-Associated Thymic Involution through Directly Affecting the Thymocytes Endocrinology, May 1, 2004; 145(5): 2392 - 2401. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Gao, M.-H. Tong, Y.-Q. Hu, Q.-S. Guo, R. Ge, and M. P. Hardy Glucocorticoid Induces Apoptosis in Rat Leydig Cells Endocrinology, January 1, 2002; 143(1): 130 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yazawa, I. Sasagawa, and T. Nakada Apoptosis of testicular germ cells induced by exogenous glucocorticoid in rats Hum. Reprod., September 1, 2000; 15(9): 1917 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schmidt, R. Gold, L. Schonrock, U. K. Zettl, H.-P. Hartung, and K. V. Toyka T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy Brain, July 1, 2000; 123(7): 1431 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirabayashi, J. Yano, T. Inoue, T. Yamaguchi, K. Tanigawara, G. E. Smyth, K. Ishiyama, T. Ohgi, K. Kimura, and T. Irimura Inhibition of Cancer Cell Growth by Polyinosinic-Polycytidylic Acid/Cationic Liposome Complex: A New Biological Activity Cancer Res., September 1, 1999; 59(17): 4325 - 4333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. McKay and J. A. Cidlowski Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways Endocr. Rev., August 1, 1999; 20(4): 435 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Nicieza, J. Huergo, B. A. Connolly, and J. Sanchez Purification, Characterization, and Role of Nucleases and Serine Proteases in Streptomyces Differentiation. ANALOGIES WITH THE BIOCHEMICAL PROCESSES DESCRIBED IN LATE STEPS OF EUKARYOTIC APOPTOSIS J. Biol. Chem., July 16, 1999; 274(29): 20366 - 20375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Urbano, R. McCaffrey, and F. Foss Isolation and Characterization of NUC70, a Cytoplasmic, Hematopoietic Apoptotic Endonuclease J. Biol. Chem., December 25, 1998; 273(52): 34820 - 34827. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Hughes Jr., C. D. Bortner, G. D. Purdy, and J. A. Cidlowski Intracellular K+ Suppresses the Activation of Apoptosis in Lymphocytes J. Biol. Chem., November 28, 1997; 272(48): 30567 - 30576. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Waterhouse, S. Kumar, Q. Song, P. Strike, L. Sparrow, G. Dreyfuss, E. S. Alnemri, G. Litwack, M. Lavin, and D. Watters Heteronuclear Ribonucleoproteins C1 and C2, Components of the Spliceosome, Are Specific Targets of Interleukin 1beta -converting Enzyme-like Proteases in Apoptosis J. Biol. Chem., November 15, 1996; 271(46): 29335 - 29341. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bicknell, R. Snowden, and G. Cohen Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937 J. Cell Sci., January 9, 1994; 107(9): 2483 - 2489. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |